Evidence Based QUality Improvement for Prescribing Stewardship in ICU (EQUIPS-ICU)
NCT06666738 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 6300
Last updated 2024-10-31
Summary
The goal of this observational study is to learn about the implementation of a process to review antimicrobial prescriptions for adult patients in Intensive Care Unit (ICU).
The main question it aims to answer is: can a structured antimicrobial review can be implemented in ICUs?
Implementation will be supported by the use of local protocols, audit and feedback, and education. It will be evaluated by daily data collection of clinical processes and interviews with local champions.
Resources to conduct the study are provided by the Wellcome Flagship Innovations award. ("Collaboration for Research, Implementation and Training in Critical Care in Asia and Africa", reference 224048/Z/21/Z).
Conditions
- Antimicrobial Stewardship
Interventions
- BEHAVIORAL
-
Structured antimicrobial review
The appropriateness of the documented indication, route of administration, expected duration and stop date of all antimicrobials will be reviewed within 48 hours of their prescription.
Sponsors & Collaborators
-
Nat Intensive Care Surveillence-MORU
collaborator UNKNOWN -
University of Oxford
lead OTHER
Principal Investigators
-
Abi Beane, Dr. · University of Oxford
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2024-11-30
- Primary Completion
- 2025-05-31
- Completion
- 2025-09-30
More Related Trials
-
Evaluation of an ICU-specific Questionnaire for Patient-reported Outcome Measures
NCT02767180 ·Status: COMPLETED
-
Pneumonia in the Intensive Care Unit (ICU) Setting
NCT02685930 ·Status: COMPLETED
-
Sepsis in Respiratory Intensive Care Unit
NCT05240157 ·Status: COMPLETED
-
Multiple Biomarkers in ICU Sepsis Patients
NCT03802136 ·Status: UNKNOWN
-
Sepsis in ICU:Causes and Outcomes of Sepsis in Diabetics Versus Non Diabetics in Assiut University Hospital
NCT04015752 ·Status: UNKNOWN
-
Assessment of Red Cell Distribution Width's Prognostic Ability in Septic Intensive Care Unit Patients
NCT06847451 ·Status: COMPLETED
-
ESICM UNITE COVID-19 Project (UNITE-COVID)
NCT04836065 ·Status: COMPLETED
-
Intensive Care Unit Procedure Related Infections
NCT06209151 ·Status: COMPLETED
-
Diagnostic Performance and Impact of a Multiplex PCR Pneumonia Panel in ICU Patients With Severe Pneumonia.
NCT05624684 ·Status: COMPLETED
-
Outcomes of Patients With COVID-19 in the Intensive Care Unit
NCT04336345 ·Status: COMPLETED
-
Functional ICUS in Uganda and Their Survival Outcomes
NCT03511742 ·Status: UNKNOWN
-
Characterization and Verification of the Intensive Care Standard Operating Procedure (SOP) Adherence of the Treated COVID-19 Patients
NCT04818463 ·Status: COMPLETED
-
Nutrition Practice in Critically Ill Adults
NCT06576895 ·Status: RECRUITING
-
Outcomes and Prognostic Factors in COVID-19
NCT04321265 ·Status: UNKNOWN
-
Differences in Care Provided in Intensive Care Units (ICUs) With Physician Versus Nurse Practitioner First Responders
NCT01323816 ·Status: COMPLETED
-
PREdiction of DIagnosed Covid-19 infecTion in IUC Patients
NCT04327180 ·Status: COMPLETED
-
The Gut Microbiome - Source of Sepsis and Novel Target in Intensive Care Units?
NCT06749483 ·Status: RECRUITING
-
The Critical Care Recovery Program: Use of a Structured Clinic Visit to Reduce Adverse Drug Events in ICU Survivors
NCT06723860 ·Status: NOT_YET_RECRUITING
-
Oxidative Monitoring in ICU Patients.
NCT02114853 ·Status: UNKNOWN
-
Clinical Characteristics of Critically Ill Patients With COVID-19
NCT04413435 ·Status: COMPLETED
-
5 Years Quality of Life and Early Mobilization in ICU
NCT05527678 ·Status: COMPLETED
-
Anti-pyretic Therapy in Critically Ill Adults
NCT01173367 ·Status: COMPLETED ·Phase: PHASE2
-
Long Term Outcome in ICU Treated COVID-19: Risk Factors for 1-year Mortality
NCT05063747 ·Status: COMPLETED
-
The IndONEsia ICCU Registry: a Multicenter Cohort of Intensive Cardiovascular Care Units Patients in Indonesia
NCT06265714 ·Status: COMPLETED
-
Hypoxia Inducible Factor 1 Alpha as a Novel Biomarker in Septic Shock
NCT02163473 ·Status: COMPLETED